News | Magnetic Resonance Imaging (MRI) | May 29, 2025

Latest Swoop system software delivers a substantial increase in image quality for AI-powered portable MR brain imaging.


May 29, 2025 — Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop system — has announced FDA clearance of its next-generation software.

This tenth-generation release delivers a substantial increase in image quality for ultra-low-field MR imaging. Optive AI software enhances each stage of the imaging process   — from noise cancellation and image acquisition to reconstruction and post-processing. The result is brain images with greater clarity uniformity, and sharper anatomical detail. These advanced AI algorithms are applied across all sequences.

Earlier this year, Hyperfine released the software at select clinical sites where early users responded enthusiastically to the image quality improvements, with some reporting that image quality is approaching that of conventional 1.5 tesla MRI scanners. This feedback underscores the clarity and consistency of the new images that can enhance patient care.

“This software release marks the beginning of a transformative era for Hyperfine. The advanced AI algorithms integrated into our new software platform dramatically elevate image quality at ultra-low field strength, enabling more confident diagnoses at the point of care. We previewed Optive AI software at the recent American Society of Neuroradiology annual meeting and received outstanding feedback. It’s the strongest signal yet of where we’re headed—and how far AI-powered portable MRI imaging can go,” said Rafael O’Halloran, Hyperfine Vice President of Technology.

“Optive AI software is our tenth software release since initial FDA clearance and marks a critical inflection point in the evolution of Swoop® system technology—the first of two major technology milestones we have been looking forward to this year. The significant image quality enhancements enabled by Optive AI software will serve as a catalyst for our 2025 growth strategy, supporting expansion into new hospital sites of care and our entry into the neurology office market,” said Tom Teisseyre, Hyperfine Chief Operating Officer.

Hyperfine plans to initiate the rollout of Optive AI software to accounts in the third quarter of 2025.

For more information about the Swoop AI-powered portable MRI system, please visit hyperfine.io.


Related Content

News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Pediatric Imaging

Sept. 29, 2026 — Visiana has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Time October 02, 2026
arrow
News | Radiation Oncology

Sept. 23, 2026 — GE HealthCare has announced a new collaboration with a research team at Mass General Brigham to explore ...

Time October 02, 2026
arrow
Feature | Digital Pathology | Kyle Hardner

As recently as a decade ago, pathology technology was expected to become more expensive, larger and more precise. Yet in ...

Time October 02, 2026
arrow
News | RSNA

Sept. 22, 2026 — The Radiological Society of North America (RSNA) is now offering a certificate program that equips ...

Time September 24, 2026
arrow
News | Computed Tomography (CT)

Sept. 21, 2026 — a2z Radiology AI has announced FDA clearance of a2z-Abdo-Triage for 10 findings on abdomen-pelvis CT ...

Time September 21, 2026
arrow
News | Radiation Oncology

Sept.21, 2026 — Radformation, a provider of intelligent automation solutions for radiation oncology, has expanded U.S ...

Time September 21, 2026
arrow
News | X-Ray

Sept. 16, 2026 —DeepHealth has received FDA 510(k) clearance for Chest XRay,¹ a chest X-ray computer-aided detection ...

Time September 18, 2026
arrow
Subscribe Now